{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:37:12Z","timestamp":1767994632065,"version":"3.49.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/ftd.0000000000000012","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T19:17:24Z","timestamp":1387826244000},"page":"406-409","source":"Crossref","is-referenced-by-count":34,"title":["Influence of Uridine Diphosphate Glucuronosyltransferase 2B7 \u2212161C>T Polymorphism on the Concentration of Valproic Acid in Pediatric Epilepsy Patients"],"prefix":"10.1097","volume":"36","author":[{"given":"Kazuyuki","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-19-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/1059-1311(92)90037-2","article-title":"Therapeutic drug monitoring improves seizure control and reduces anticonvulsant side-effects in patients with refractory epilepsy.","volume":"1","author":"McKee","year":"1992","journal-title":"Seizure"},{"key":"R3-19-20210129","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2165\/00003088-199529060-00005","article-title":"Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness.","volume":"29","author":"Eilers","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"R4-19-20210129","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0022-3565(24)37076-4","article-title":". Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid.","volume":"283","author":"Sadeque","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R5-19-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":". Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C911 genotype.","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol Sci"},{"key":"R6-19-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007691-198903000-00002","article-title":". Urinary excretion of valproate and some metabolites in chronically treated patients.","volume":"11","author":"Dickinson","year":"1989","journal-title":"Ther Drug Monit"},{"key":"R7-19-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","article-title":"Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10.","volume":"37","author":"Argikar","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"R8-19-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.tpj.6500210","article-title":". Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes.","volume":"3","author":"Ho","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"R9-19-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/DMR-120023681","article-title":"PM frequencies of major CYPs in Asians and Caucasians.","volume":"35","author":"Mizutani","year":"2003","journal-title":"Drug Metab Rev"},{"key":"R10-19-20210129","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0026-895X(24)26503-2","article-title":"Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter.","volume":"57","author":"Ishii","year":"2000","journal-title":"Mol Pharmacol"},{"key":"R11-19-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2710.1999.00201.x","article-title":"Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.","volume":"24","author":"Tanaka","year":"1999","journal-title":"J Clin Pharm Ther"},{"key":"R12-19-20210129","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/dmd.106.009340","article-title":". In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction.","volume":"34","author":"Rowland","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"R13-19-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","article-title":"Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs.","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol"},{"key":"R14-19-20210129","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/j.1875-9114.2012.01028.x","article-title":". Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.","volume":"32","author":"Walzer","year":"2012","journal-title":"Pharmacotherapy"},{"key":"R15-19-20210129","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00003088-200544050-00005","article-title":". Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy.","volume":"44","author":"Ragueneau-Majlessi","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R16-19-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1528-1157.2003.25302.x","article-title":"Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.","volume":"44","author":"Coupez","year":"2003","journal-title":"Epilepsia"},{"key":"R17-19-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1528-1157.1994.tb02926.x","article-title":". Lack of interaction of gabapentin with carbamazepine or valproate.","volume":"35","author":"Radulovic","year":"1994","journal-title":"Epilepsia"},{"key":"R18-19-20210129","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.clinbiochem.2006.01.023","article-title":". Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort.","volume":"39","author":"Moridani","year":"2006","journal-title":"Clin Biochem"},{"key":"R19-19-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.50.2.259","article-title":". Developmental aspects of human hepatic drug glucuronidation in young children and adults.","volume":"50","author":"Strassburg","year":"2002","journal-title":"Gut"},{"key":"R20-19-20210129","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2133\/dmpk.DMPK-11-NT-144","article-title":". Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.","volume":"27","author":"Guo","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"R21-19-20210129","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0090-9556(24)02990-8","article-title":". Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.","volume":"32","author":"Saeki","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"R22-19-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clinbiochem.2006.01.002","article-title":". Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects.","volume":"39","author":"Saito","year":"2006","journal-title":"Clin Biochem"},{"key":"R23-19-20210129","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2133\/dmpk.DMPK-10-SC-021","article-title":". Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population.","volume":"25","author":"Hwang","year":"2010","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:53:01Z","timestamp":1746089581000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201406000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000012","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}